Asset Details
Do you wish to reserve the book?
Highlights from the 58th meeting of the American Society of Haematology, 1–6 December 2016, San Diego, USA
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Highlights from the 58th meeting of the American Society of Haematology, 1–6 December 2016, San Diego, USA
Do you wish to request the book?
Highlights from the 58th meeting of the American Society of Haematology, 1–6 December 2016, San Diego, USA
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Highlights from the 58th meeting of the American Society of Haematology, 1–6 December 2016, San Diego, USA
2017
Overview
The recent 58th Annual American Society of Haematology (ASH) meeting held in San Diego shed light on the usual mixture of groundbreaking basic and translational science and the recent practice-changing clinical trials. Recurrent themes this year were the use of recent next-generation sequencing (NGS) techniques to perfect prognostic stratification and disease monitoring. Newer prospects on the role of metabolism in normal and malignant haemopoiesis and mature data on long-awaited trials on immunotherapy and CAR-T cells in lymphoid neoplasms were also discussed.
